TipRanks on MSN
HeartBeam (NASDAQ: BEAT) secures FDA 510(k) clearance for 12-lead ECG synthesis software following successful appeal
Austin, Texas, United States, December 10th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming ...
Unlike any single-lead or 6-lead consumer device, HeartBeam’s patented cable-free technology captures the heart’s electrical signals in three non-coplanar dimensions and synthesizes them into a ...
Medical Device Network on MSN
FDA clears HeartBeam’s at-home arrhythmia assessment tool
HeartBeam’s ECG software duplicates the 12-lead ECG approach undertaken in healthcare settings with electrodes to evaluate heart arrhythmias.
Telemed Solutions, a cardiac device company, announced today the release of its initial product, the TM-12. The TM-12 is a PC-based wireless 12-Lead EKG system. It embeds a Bluetooth radio into an ECG ...
Twelve-lead ECGs, although standard in hospitals, can be bulky and impractical for home use. On the other hand, Apple Watch’s ECG app is easy to use, but it is limited in what it can detect because it ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, ...
An asymptomatic male patient with definite LQTS with a normal ECG and QTc who was flagged by the AI. Photo Credit: J. Martijn Bos and Michael Ackerman. A new artificial intelligence (AI) solution ...
A 65-year-old man receives a right coronary artery stent after a NSTEMI. What does his postsurgery ECG look like?
Artificial intelligence (AI) can detect signs of existing or emerging A-fib in ECGs that exhibit normal sinus rhythm, Mayo Clinic researchers have found. Their retrospective analysis, published online ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback